Baripeg P Drop 15ml contains Pegaptanib, an anti-VEGF (vascular endothelial growth factor) agent used to treat neovascular (wet) age-related macular degeneration (AMD). It works by inhibiting abnormal blood vessel growth and fluid leakage in the retina, reducing swelling and preventing further vision loss. Regular use as prescribed by an ophthalmologist helps preserve vision and slow disease progression.

Uses

• Treats wet age-related macular degeneration (AMD)

• Reduces retinal swelling

• Prevents abnormal blood vessel growth in the eye

• Protects against vision loss

• Supports long-term eye health

Benefits

• Helps preserve vision in AMD patients

• Reduces fluid accumulation and swelling in the retina

• Slows disease progression

• Improves visual clarity and daily comfort

• Safe when used as prescribed by an ophthalmologist

Dosage

• Administer as prescribed by your ophthalmologist, usually via intravitreal injection

• Follow all sterile procedures to prevent infection

• Frequency and duration depend on disease severity and doctor’s guidance

Side Effects

• Eye irritation or redness

• Increased intraocular pressure

• Rarely, eye infection or retinal detachment

• Mild pain at the injection site

FAQs

Q1: What is Baripeg P Drop 15ml used for?

It treats wet age-related macular degeneration and protects vision.

Q2: How does it work?

Pegaptanib inhibits abnormal blood vessel growth and fluid leakage in the retina.

Q3: Can it be used daily?

Use only as prescribed by an ophthalmologist; it is typically administered at intervals.

Q4: Are there side effects?

Mild eye irritation or increased pressure may occur; serious complications are rare.

Q5: How quickly does it work?

Effects on swelling and vision may be noticed over weeks; long-term treatment slows disease progression.

Q6: Can it be used with other eye medications?

Consult your ophthalmologist before combining with other treatments.

Q7: Is it safe for children?

It is generally prescribed only for adults under ophthalmologist supervision.